CytoAgents, Inc. — Form D
CytoAgents, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-16. The offering totals $15.2M, of which $7.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-05-16
- Form: D
- Accession: 0001877258-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $15.2M
- Amount sold: $7.0M
- Remaining: $8.2M
- Investors: 23
- Date of first sale: 2023-05-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-481794
Issuer
- Name: CytoAgents, Inc.
- CIK: 0001877258
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 100 S COMMONS #102, PITTSBURGH, PA, 15212
- Phone: 412-303-1200
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert L Ferris | Director | Pittsburgh, PA |
| STANLEY MARKS | Director | PITTSBURGH, PA |
| Anthony McCarley | Director | Pittsbsurgh, PA |
| Catherine Mott | Director | Pittsburgh, PA |
| Teresa Whalen | Director | Pittsburgh, PA |
| Roy L Prieb | Executive Officer | Pittsburgh, PA |
| Teresa Whalen | Executive Officer | Pittsburgh, PA |
| John Friedman | Director | New York, NY |
Other filings by this issuer (1)
More